Answers are grounded in this paper and cite their sources.
This study aimed to compare surgical outcomes between minimally invasive surgery (MIS) and open surgery in overweight or obese patients with borderline ovarian tumor (BOT) and identify risk factors for additional analgesic use despite patient-controlled analgesia .We selected patients with a body mass index of 25 or more who underwent surgery for BOT at Korea University Anam Hospital from 2006 to 2023. Patients who underwent laparoscopic or robotic surgery were categorized into the MIS group, while those who underwent open surgery were categorized into the open surgery group. For statistical analysis, the Student t test, chi-square test, Fisher exact test, and logistic regression analysis were performed using SPSS. Of 128 patients, 90 were in the MIS group, and 38 were in the open group. Compared with the open surgery group, the MIS group had a shorter surgical time ( P < .001), lower estimated blood loss ( P < .001), a shorter hospital stay ( P < .001), and a lower rate of additional analgesic use despite patient-controlled analgesia ( P = .002). There was no significant difference in disease-free survival between the 2 groups. No deaths occurred during follow-up. MIS compared to open surgery was identified as a factor associated with significantly lower use of additional analgesics (adjusted odds ratio, 0.13; 95% confidence interval, 0.037–0.470; P = .002). In overweight or obese patients with BOT, MIS was associated with better surgical outcomes and a reduced need for additional analgesics during hospitalization compared with open surgery. These findings suggest that MIS may be a feasible surgical option for these patients.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: